• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种人类载脂蛋白C-III变体的分子克隆:苏氨酸74→丙氨酸74突变阻止O-糖基化。

Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation.

作者信息

Maeda H, Hashimoto R K, Ogura T, Hiraga S, Uzawa H

机构信息

Department of Molecular Genetics, Kumamoto University Medical School, Japan.

出版信息

J Lipid Res. 1987 Dec;28(12):1405-9.

PMID:3123586
Abstract

Apolipoprotein C-III (apoC-III) is a major protein of very low density lipoprotein (VLDL). The apoC-III polypeptide contains a carbohydrate chain containing galactosamine, galactose, and sialic acid attached in O-linkage to a threonine residue at position 74. We have cloned the apoC-III gene from a subject whose serum contained unusually high amounts of apoC-III lacking the carbohydrate moiety (C-III-0). DNA sequence analysis of the cloned gene revealed a single nucleotide substitution (A----G) that encodes an alanine at position 74 instead of the normal threonine. As a result of this amino acid replacement, the mutant apoC-III polypeptide is not glycosylated. The mutation in the apoC-III gene creates a novel AluI site that permits diagnosis of the change by Southern blotting of genomic DNA.

摘要

载脂蛋白C-III(apoC-III)是极低密度脂蛋白(VLDL)的主要蛋白质。apoC-III多肽含有一条碳水化合物链,该链包含以O-连接方式连接到第74位苏氨酸残基上的半乳糖胺、半乳糖和唾液酸。我们从一名血清中含有异常高含量缺乏碳水化合物部分的apoC-III(C-III-0)的受试者中克隆了apoC-III基因。对克隆基因的DNA序列分析显示,存在一个单核苷酸替换(A→G),该替换在第74位编码丙氨酸而非正常的苏氨酸。由于这种氨基酸替换,突变的apoC-III多肽未被糖基化。apoC-III基因中的突变产生了一个新的AluI位点,这使得通过基因组DNA的Southern印迹法能够诊断出这种变化。

相似文献

1
Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation.一种人类载脂蛋白C-III变体的分子克隆:苏氨酸74→丙氨酸74突变阻止O-糖基化。
J Lipid Res. 1987 Dec;28(12):1405-9.
2
A novel apolipoprotein C-III variant, apoC-III(Gln38-->Lys), associated with moderate hypertriglyceridemia in a large kindred of Mexican origin.一种新的载脂蛋白C-III变体,即载脂蛋白C-III(谷氨酰胺38→赖氨酸),与一个来自墨西哥的大家族中的中度高甘油三酯血症相关。
J Lipid Res. 1997 Sep;38(9):1833-40.
3
The apolipoprotein C-II variant apoC-IILys19-->Thr is not associated with dyslipidemia in an affected kindred.
Clin Genet. 1994 Jun;45(6):292-7. doi: 10.1111/j.1399-0004.1994.tb04033.x.
4
Characterization of the lipid-binding properties and lipoprotein lipase inhibition of a novel apolipoprotein C-III variant Ala23Thr.新型载脂蛋白C-III变体Ala23Thr的脂质结合特性及脂蛋白脂肪酶抑制作用的表征
J Lipid Res. 2000 Nov;41(11):1760-71.
5
Electrophoretic screening for genetic variation in apolipoprotein C-III: identification of a novel apoC-III variant, apoC-III(Asp45-->Asn), in a Turkish patient.载脂蛋白C-III基因变异的电泳筛查:在一名土耳其患者中鉴定出一种新型载脂蛋白C-III变异体,即载脂蛋白C-III(Asp45→Asn)
J Lipid Res. 1994 Aug;35(8):1431-40.
6
Isolation and characterization of cDNA clones corresponding to two different human apoC-III alleles.与两种不同人类载脂蛋白C-III等位基因相对应的cDNA克隆的分离与鉴定。
J Lipid Res. 1985 Apr;26(4):451-6.
7
Linkage, evolution, and expression of the rat apolipoprotein A-I, C-III, and A-IV genes.大鼠载脂蛋白A-I、C-III和A-IV基因的连锁、进化及表达
J Biol Chem. 1986 Oct 5;261(28):13268-77.
8
Apolipoprotein C-III0 lacks carbohydrate residues: use of mass spectrometry to study apolipoprotein structure.
J Lipid Res. 1989 Nov;30(11):1781-7.
9
Sequences and expression of the porcine apolipoprotein A-I and C-III mRNAs.猪载脂蛋白A-I和C-III mRNA的序列与表达
Gene. 1993 Jan 30;123(2):173-9. doi: 10.1016/0378-1119(93)90121-i.
10
A deletion mutation in the ApoC-II gene (ApoC-II Nijmegen) of a patient with a deficiency of apolipoprotein C-II.一名载脂蛋白C-II缺乏患者的ApoC-II基因(ApoC-II奈梅亨型)存在缺失突变。
J Biol Chem. 1988 Dec 5;263(34):17913-6.

引用本文的文献

1
Multifaceted Role of Apolipoprotein C3 in Cardiovascular Disease Risk and Metabolic Disorder in Diabetes.载脂蛋白C3在糖尿病心血管疾病风险和代谢紊乱中的多方面作用
Int J Mol Sci. 2024 Nov 27;25(23):12759. doi: 10.3390/ijms252312759.
2
Exploring apolipoprotein C-III: pathophysiological and pharmacological relevance.探索载脂蛋白 C-III:病理生理学和药理学相关性。
Cardiovasc Res. 2024 Feb 17;119(18):2843-2857. doi: 10.1093/cvr/cvad177.
3
Systematic Assessment of Protein C-Termini Mutated in Human Disorders.系统性评估人类疾病中突变的蛋白质 C 末端。
Biomolecules. 2023 Feb 12;13(2):355. doi: 10.3390/biom13020355.
4
The apolipoprotein C-III (Gln38Lys) variant associated with human hypertriglyceridemia is a gain-of-function mutation.载脂蛋白 C-III (Gln38Lys) 变异与人类高甘油三酯血症相关,是一种获得性功能突变。
J Lipid Res. 2017 Nov;58(11):2188-2196. doi: 10.1194/jlr.M077313. Epub 2017 Sep 8.
5
Reduced apolipoprotein glycosylation in patients with the metabolic syndrome.代谢综合征患者载脂蛋白糖基化减少。
PLoS One. 2014 Aug 12;9(8):e104833. doi: 10.1371/journal.pone.0104833. eCollection 2014.
6
A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolates.一种罕见的功能性心脏保护 APOC3 变异体在不同的人群隔离群体中频率增加。
Nat Commun. 2013;4:2872. doi: 10.1038/ncomms3872.
7
Targeting the glycoproteome.靶向糖蛋白组。
Glycoconj J. 2013 Feb;30(2):119-36. doi: 10.1007/s10719-012-9438-6. Epub 2012 Aug 11.
8
Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.GALNT2 功能丧失性突变杂合子可改善人类血浆甘油三酯清除率。
Cell Metab. 2011 Dec 7;14(6):811-8. doi: 10.1016/j.cmet.2011.11.005.
9
The Tn antigen-structural simplicity and biological complexity.Tn 抗原——结构简单而生物学特性复杂。
Angew Chem Int Ed Engl. 2011 Feb 18;50(8):1770-91. doi: 10.1002/anie.201002313. Epub 2011 Jan 21.
10
Quantitative analysis of intact apolipoproteins in human HDL by top-down differential mass spectrometry.采用自上而下的差异质谱法对人 HDL 中的完整载脂蛋白进行定量分析。
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7728-33. doi: 10.1073/pnas.0910776107. Epub 2010 Apr 13.